Bae Jae-Han, Ryu Jae-Chan, Ha Sang Hee, Cho Min Soo, Cha Myung-Jin, Chang Jun Young, Kang Dong-Wha, Kwon Sun U, Kim Jong S, Kim Bum Joon
Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea.
Department of Neurology, Gimcheon Jeil Hospital, Gimcheon, South Korea.
BMC Neurol. 2025 Jan 11;25(1):15. doi: 10.1186/s12883-024-04008-0.
Detection of atrial fibrillation (AF) in patients with embolic stroke of undetermined source (ESUS) is important for the secondary prevention of stroke. We investigated the factors associated with the detection of newly diagnosed AF in ESUS patients during follow-up.
Patients with acute ischemic stroke classified as ESUS were included. All patients underwent transthoracic echocardiography and Holter to detect the source of embolism. Structural, electrophysiological markers of left atrial cardiopathy (i.e., left atrial enlargement [LAE], non-sustained tachycardia [NSAT]) as well as lesion patterns of ischemic stroke were examined. Implantable loop recorder (ILR) was implanted in selective patients. Sensitivity and positive predictive value analysis was used to assess the predictive value for AF detection.
Among 312 patients with ESUS, AF was detected in 24 (7.7%) patients during follow-up. Patients with AF had a higher prevalence of LAE, NSAT, and the imaging pattern of confluent plus additional lesions in a single vascular territory. Multivariable analysis showed that ILR implantation (hazards ratio 11.497 [95% confidence interval 3.795-34.818]), LAE (3.204 [1.096-9.370]), NSAT (4.070 [1.378-12.018]), and confluent plus additional lesions (4.977 [1.649-15.019]) were independent predictors of AF detection. The sensitivity of detecting AF in those with LAE, NSAT, or confluent plus additional lesions pattern was 91.7%. The positive predictive value of detecting AF in those with LAE, NSAT and confluent plus additional lesions pattern was 40.0%.
In conclusion, patients with LAE, NSAT, or confluent plus additional lesions may benefit from ILR monitoring detecting new AF.
在不明来源栓塞性卒中(ESUS)患者中检测心房颤动(AF)对于卒中的二级预防很重要。我们调查了ESUS患者随访期间新诊断AF检测的相关因素。
纳入分类为ESUS的急性缺血性卒中患者。所有患者均接受经胸超声心动图和动态心电图检查以检测栓塞来源。检查左心房心肌病的结构、电生理标志物(即左心房扩大[LAE]、非持续性心动过速[NSAT])以及缺血性卒中的病变模式。对部分患者植入植入式循环记录仪(ILR)。采用敏感性和阳性预测值分析评估AF检测的预测价值。
在312例ESUS患者中,随访期间有24例(7.7%)检测到AF。AF患者中LAE、NSAT以及单个血管区域融合加额外病变的影像学模式的患病率更高。多变量分析显示,ILR植入(风险比11.497[95%置信区间3.795 - 34.818])、LAE(3.204[1.096 - 9.370])、NSAT(4.070[1.378 - 12.018])和融合加额外病变(4.977[1.649 - 15.019])是AF检测的独立预测因素。LAE、NSAT或融合加额外病变模式患者中检测AF的敏感性为91.7%。LAE、NSAT和融合加额外病变模式患者中检测AF的阳性预测值为40.0%。
总之,LAE、NSAT或融合加额外病变的患者可能受益于ILR监测以检测新发AF。